(Q69724063)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2778113%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

title

Chlorambucil--an effective corticosteroid-sparing therapy for pyoderma gangrenosum (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2778113%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference

J P Callen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2778113%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

J D Case

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2778113%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

D Sager

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2778113%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

language of work or name

English

0 references

publication date

1 September 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2778113%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

5 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2778113%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2778113%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

issue

3 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2778113%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

page(s)

515-519

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2778113%20AND%20SRC:MED&resulttype=core&format=json

Pyoderma gangrenosum; a clinical study of nineteen cases

5 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970218-8

7 January 2021

Pyoderma gangrenosum with response to cyclophosphamide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970218-8

7 January 2021

Direct immunofluorescence in pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970218-8

7 January 2021

Pyoderma gangrenosum and leucocytoclastic vasculitis in association with rheumatoid arthritis--a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970218-8

7 January 2021

Pharmacological modulation of neutrophil phagocytic function in a patient with recurrent sepsis, pyoderma gangrenosum and impaired phagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970218-8

7 January 2021

Pyoderma gangrenosum, altered delayed hypersensitivity and polyarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970218-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970218-8

1 reference

7 January 2021

Diaminodiphenylsulfone and steroids in the treatment of pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970218-8

7 January 2021

Clofazimine. A new agent for the treatment of pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970218-8

7 January 2021

Pyoderma gangrenosum treated with cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970218-8

7 January 2021

Pyoderma gangraenosum (dermatitis ulcerosa) and monoclonal (IgA) globulin healed after melphalan treatment. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970218-8

7 January 2021

10.1016/S0190-9622(89)70218-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2778113%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference